Pfizer Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Great. Good morning, everybody, and thank you for participating in the final day of our SVB Global Healthcare Conference. My name is Dave Risinger. I cover diversified biopharmaceuticals, and it's very much my pleasure to welcome leaders from the Pfizer leadership team.
So with us this morning, we have Andy Schmeltz. He's Senior Vice President of Commercial Strategy and Innovation; and Navin Katyal, who is U.S. Commercial and Global Business Lead for the mRNA portfolio. So we're fortunate to have them both here with us today, and just wanted to extend my thanks to you both for taking the time to join us.
Questions & Answers
I thought we'd start off with a high-level question for you, Andy. I know that you obviously kicked off a very helpful discussion on Pfizer's innovation initiatives at your analyst meeting in early December. But it would be helpful for you to just sort of summarize that, highlight
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
